Pulling SEC filings + quote and writing the call…

Skyward Specialty Insurance Group, Inc.
Next earnings Jul 29, 2026 · consensus $1.21 EPS, $480M rev
Last earnings -0.2% on 2026-05-06
High-ROE specialty insurer compounding net income 45%/yr at a modest 14.8x P/E — quality at a fair price.
Diluted EPS $4.07 · FY2025
Quality fundamentals and an attractive price line up (~152% below fair value) — the rarer case where both the business and the entry look good.
Skyward is a fast-growing E&S/specialty P&C insurer executing a coherent 'Rule Our Niche' strategy across nine diversified underwriting divisions. The headline 'revenue $12.4M' XBRL figure is a tag-extraction artifact (RevenueFromContractWithCustomerExcludingAssessedTax) and is not the real top line — and the derived 1,373% net margin and 216x P/S that follow from it are meaningless and should be discarded. The MD&A reveals the true scale: gross written premiums of $2.17B (up from $1.74B) and net written premiums of $1.41B in FY2025. Against that, $170M of net income is a roughly 12% net margin on net written premium — healthy for a specialty underwriter and consistent with a 16.8% ROE.
The earnings trajectory is the core of the bull case: net income has compounded from $38.3M (FY2021) to $170M (FY2025), with FY2025 up 43% and diluted EPS up 41.8% to $4.07. Operating cash flow of $408M (+33.7%) comfortably exceeds reported net income and funds growth internally; capex is trivial at $5.45M. The balance sheet carries $1.01B of equity (+27%) and $169M cash, with retained earnings up 175% as the company shifts from a recent-IPO posture to a self-funding compounder. Liabilities/equity of 3.75x is normal for an insurer (it reflects loss reserves and unearned premium, not financial leverage).
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 12:01 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.97M | $5.20M | $9.82M | $10.7M | $12.4M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $38.3M | $39.4M | $86.0M | $119M | $170M |
| Diluted EPS | $1.18 | $1.21 | $2.24 | $2.87 | $4.07 |
| Net margin | 964.4% | 757.8% | 875.7% | 1113.0% | 1373.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q1 2026 (per. 3/31): first quarter consolidating Apollo Group results
Q1 2026 (per. 3/31): first quarter consolidating Apollo Group results
Q1 2026 earnings release; first quarter consolidating the Apollo acquisition
2026 proxy: board slate, exec comp, auditor ratification
Amends Apollo-close 8-K to add required pro forma financial statements
FY2025 10-K: net income $170M (+43%), equity $1.0B, GWP $2.17B
Executive/board change disclosed (Item 5.02 leadership transition)
FY2025 results release: net income ~$170M, diluted EPS $4.07 (+42%)
Closed $555M Apollo acquisition: $300M term loan + 3.7M new shares issued
Sources: SEC EDGAR (CIK 0001519449, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 6/30/2026, 4:01:59 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 3 open-market buys · 4 sales
| 2026-06-12 | Schmitt Thomas N CPO, Skyward Group | Sell | 8.40K @ $51.32 | $431K |
| 2026-05-21 | Kuczinski Anthony J Director | Buy | 200.00 @ $47.00 | $9.40K |
| 2026-05-21 | Kuczinski Anthony J Director | Buy | 800.00 @ $47.00 | $37.6K |
| 2026-05-21 | Kuczinski Anthony J Director | Buy | 1.00K @ $47.20 | $47.2K |
| 2026-05-11 | Ashe Gena L Director | Exercise | 1.80K | |
| 2026-05-11 | Ashe Gena L Director | Sell | 100.00 @ $46.35 | $4.63K |
| 2026-05-11 | Ashe Gena L Director | Sell | 140.00 @ $46.35 | $6.49K |
| 2026-05-11 | Ashe Gena L Director | Sell | 500.00 @ $46.35 | $23.2K |
| 2026-05-06 | Schmitt Thomas N CPO, Skyward Group | Exercise | 3.36K | |
| 2026-05-06 | Schmitt Thomas N CPO, Skyward Group | Tax | 1.32K @ $43.68 | $57.7K |
| 2026-05-06 | Kapadia Sandip A Head of Actuarial | Exercise | 2.69K | |
| 2026-05-06 | Kapadia Sandip A Head of Actuarial | Tax | 1.37K @ $43.68 | $60.0K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1 buy · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.